Literature DB >> 28725951

New aspects of the vulnerability stress model in general, its relevance in schizophrenic psychoses and the place of antipsychotics.

Hans-Jürgen Möller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28725951     DOI： 10.1007/s00406-017-0825-7

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  11 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Stress is a bad advisor. Stress primes poor decision making in deluded psychotic patients.

Authors:  Steffen Moritz; Ulf Köther; Maike Hartmann; Tania M Lincoln
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-28       Impact factor: 5.270

3.  Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders.

Authors:  Nikolaos Koutsouleris; Christos Davatzikos; Stefan Borgwardt; Christian Gaser; Ronald Bottlender; Thomas Frodl; Peter Falkai; Anita Riecher-Rössler; Hans-Jürgen Möller; Maximilian Reiser; Christos Pantelis; Eva Meisenzahl
Journal:  Schizophr Bull       Date:  2013-10-13       Impact factor: 9.306

4.  Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications.

Authors:  Hans-Jürgen Möller; Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08       Impact factor: 5.270

Review 5.  Pharmacological treatment of negative symptoms in schizophrenia.

Authors:  Hans-Jürgen Möller; Pal Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-04-21       Impact factor: 5.270

6.  Subjective emotional over-arousal to neutral social scenes in paranoid schizophrenia.

Authors:  Evelina Haralanova; Svetlozar Haralanov; Anna Beraldi; Hans-Jürgen Möller; Kristina Hennig-Fast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-27       Impact factor: 5.270

7.  Rate and predictors of psychotic symptoms after Kashmir earthquake.

Authors:  Muhammad Ayub; Khalid Saeed; David Kingdon; Farooq Naeem
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-25       Impact factor: 5.270

Review 8.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

Review 9.  The effects of physical exercise in schizophrenia and affective disorders.

Authors:  Berend Malchow; Daniela Reich-Erkelenz; Viola Oertel-Knöchel; Katriona Keller; Alkomiet Hasan; Andrea Schmitt; Thomas W Scheewe; Wiepke Cahn; René S Kahn; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-20       Impact factor: 5.270

10.  Psychopathology: genetics and the stress-vulnerability hypothesis.

Authors:  Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-04       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.